Aurobindo Pharma, part of the pharma space, has rallied more than 100% in FY24 but found some resistance above Rs 1,100 levels in January 2024. The stock underwent price wise correction since January 2024 and is now showing signs of bottoming out which suggests that bulls are ready to take the charge again. Short-term traders … Read more
Foreign brokerage Jefferies has a ‘hold’ rating on M&M Finance on expectations of strong loan growth momentum. Meanwhile, domestic brokerage Nuvama has a ‘buy’ on PI Industries. We have collated a list of recommendations from top brokerage firms from ETNow: Jefferies on M&M Finance: Hold | Target: Rs 295Jefferies maintains a hold stance on Mahindra … Read more
Last calendar year was a rough year for Indian metal stocks, and all the hopes that 2023 will bring some respite for the beaten-down sector are down in the doldrums as of now. In CY23, the Nifty Metal index recorded a decline of roughly 15%, making it the second worst performer, with Nifty Media leading … Read more
DLF, part of the real estate industry, gave a breakout from a rectangle pattern on the weekly charts to hit a fresh 52-week high in April 2023 and has opened room for the stock to inch towards Rs 470 levels, suggest experts. The stock price hit a 52-week high of Rs 419 on 17 April … Read more
Shares of Container Corp. of India () did not see a follow-up rally on Thursday, as a cut in land license fee (LLF) on leasing of railways land for Shakti terminals could not lift analyst earnings estimates for the logistics solutions provider. Analysts seek more clarity on the subject while maintaining a ‘buy’ rating on … Read more
Shares of have fallen more than 30 per cent from their October 2021 highs, amid broader market weakness, putting the stock in the bear grip. However, brokerages have maintained their bullish stance on this smallcap company and see over 95 per cent upside on the back of strong order book and growth runway. Dolat Capital … Read more